Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITDALIZE Study
DRKS00016940Phase 3Recruiting
- Sponsor
- University Hospital Würzburg
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in Vitamin D deficiency (VDD) comparing High-dose vitamin D3 with Placebo (2 arms). Primary endpoint: 28-day all-cause mortality. Started Sep 2019; status: recruiting.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on DRKS00016940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00016940.